Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $372000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 11.0% to $372000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 3.36% year-over-year, with the annual reading at $1.6 million for FY2025, 3.36% down from the prior year.
  • Depreciation & Amortization (CF) hit $372000.0 in Q4 2025 for Camp4 Therapeutics, down from $416000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $436000.0 in Q1 2024 to a low of $372000.0 in Q4 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $418888.9 across 3 years, with a median of $421000.0 in 2025.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 1.42% in 2025; the steepest drop was 11.0% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $435000.0 in 2023, then fell by 3.91% to $418000.0 in 2024, then dropped by 11.0% to $372000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CAMP at $372000.0 in Q4 2025, $416000.0 in Q3 2025, and $430000.0 in Q2 2025.